| PCS-2023 > 3 > 3E > 3E0 > 3E05 |
3E0 | Physiological Systems and Anatomical Regions, Introduction | |
Info: | Introduction: Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products | |
3E05 | Introduction, Peripheral Artery | |
3E050 | Open | |
3E0500 | Antineoplastic | |
3E05002 | Introduction of High-dose Interleukin-2 into Peripheral Artery, Open Approach | |
3E05003 | Introduction of Low-dose Interleukin-2 into Peripheral Artery, Open Approach | |
3E05005 | Introduction of Other Antineoplastic into Peripheral Artery, Open Approach | |
3E0500M | Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Artery, Open Approach | |
3E0500P | Introduction of Clofarabine into Peripheral Artery, Open Approach | |
3E0501 | Thrombolytic | |
3E05016 | Introduction of Recombinant Human-activated Protein C into Peripheral Artery, Open | |
3E05017 | Introduction of Other Thrombolytic into Peripheral Artery, Open Approach | |
3E0502 | Anti-infective | |
3E05028 | Introduction of Oxazolidinones into Peripheral Artery, Open Approach | |
3E05029 | Introduction of Other Anti-infective into Peripheral Artery, Open Approach | |
3E0503 | Anti-inflammatory | |
3E0503Z | Introduction of Anti-inflammatory into Peripheral Artery, Open Approach | |
3E0504 | Serum, Toxoid and Vaccine | |
3E0504Z | Introduction of Serum, Toxoid and Vaccine into Peripheral Artery, Open Approach | |
3E0506 | Nutritional Substance | |
3E0506Z | Introduction of Nutritional Substance into Peripheral Artery, Open Approach | |
3E0507 | Electrolytic and Water Balance Substance | |
3E0507Z | Introduction of Electrolytic and Water Balance Substance into Peripheral Artery, Open Approach | |
3E050F | Intracirculatory Anesthetic | |
3E050FZ | Introduction of Intracirculatory Anesthetic into Peripheral Artery, Open Approach | |
3E050H | Radioactive Substance | |
3E050HZ | Introduction of Radioactive Substance into Peripheral Artery, Open Approach | |
3E050K | Other Diagnostic Substance | |
3E050KZ | Introduction of Other Diagnostic Substance into Peripheral Artery, Open Approach | |
3E050N | Analgesics, Hypnotics, Sedatives | |
3E050NZ | Introduction of Analgesics, Hypnotics, Sedatives into Peripheral Artery, Open Approach | |
3E050P | Platelet Inhibitor | |
3E050PZ | Introduction of Platelet Inhibitor into Peripheral Artery, Open Approach | |
3E050R | Antiarrhythmic | |
3E050RZ | Introduction of Antiarrhythmic into Peripheral Artery, Open Approach | |
3E050T | Destructive Agent | |
3E050TZ | Introduction of Destructive Agent into Peripheral Artery, Open Approach | |
3E050X | Vasopressor | |
3E050XZ | Introduction of Vasopressor into Peripheral Artery, Open Approach | |
3E050G | Other Therapeutic Substance | |
3E050GC | Introduction of Other Therapeutic Substance into Peripheral Artery, Open Approach | |
3E050GN | Introduction of Blood Brain Barrier Disruption Substance into Peripheral Artery, Open Approach | |
3E050V | Hormone | |
3E050VG | Introduction of Insulin into Peripheral Artery, Open Approach | |
3E050VH | Introduction of Human B-type Natriuretic Peptide into Peripheral Artery, Open Approach | |
3E050VJ | Introduction of Other Hormone into Peripheral Artery, Open Approach | |
3E050W | Immunotherapeutic | |
3E050WK | Introduction of Immunostimulator into Peripheral Artery, Open | |
3E050WL | Introduction of Immunosuppressive into Peripheral Artery, Open | |
3E053 | Percutaneous | |
3E0530 | Antineoplastic | |
3E05302 | Introduction of High-dose Interleukin-2 into Peripheral Artery, Percutaneous Approach | |
3E05303 | Introduction of Low-dose Interleukin-2 into Peripheral Artery, Percutaneous Approach | |
3E05305 | Introduction of Other Antineoplastic into Peripheral Artery, Percutaneous Approach | |
3E0530M | Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Artery, Percutaneous Approach | |
3E0530P | Introduction of Clofarabine into Peripheral Artery, Percutaneous Approach | |
3E0531 | Thrombolytic | |
3E05316 | Introduction of Recombinant Human-activated Protein C into Peripheral Artery, Percutaneous | |
3E05317 | Introduction of Other Thrombolytic into Peripheral Artery, Percutaneous Approach | |
3E0532 | Anti-infective | |
3E05328 | Introduction of Oxazolidinones into Peripheral Artery, Percutaneous Approach | |
3E05329 | Introduction of Other Anti-infective into Peripheral Artery, Percutaneous Approach | |
3E0533 | Anti-inflammatory | |
3E0533Z | Introduction of Anti-inflammatory into Peripheral Artery, Percutaneous Approach | |
3E0534 | Serum, Toxoid and Vaccine | |
3E0534Z | Introduction of Serum, Toxoid and Vaccine into Peripheral Artery, Percutaneous Approach | |
3E0536 | Nutritional Substance | |
3E0536Z | Introduction of Nutritional Substance into Peripheral Artery, Percutaneous Approach | |
3E0537 | Electrolytic and Water Balance Substance | |
3E0537Z | Introduction of Electrolytic and Water Balance Substance into Peripheral Artery, Percutaneous Approach | |
3E053F | Intracirculatory Anesthetic | |
3E053FZ | Introduction of Intracirculatory Anesthetic into Peripheral Artery, Percutaneous Approach | |
3E053H | Radioactive Substance | |
3E053HZ | Introduction of Radioactive Substance into Peripheral Artery, Percutaneous Approach | |
3E053K | Other Diagnostic Substance | |
3E053KZ | Introduction of Other Diagnostic Substance into Peripheral Artery, Percutaneous Approach | |
3E053N | Analgesics, Hypnotics, Sedatives | |
3E053NZ | Introduction of Analgesics, Hypnotics, Sedatives into Peripheral Artery, Percutaneous Approach | |
3E053P | Platelet Inhibitor | |
3E053PZ | Introduction of Platelet Inhibitor into Peripheral Artery, Percutaneous Approach | |
3E053R | Antiarrhythmic | |
3E053RZ | Introduction of Antiarrhythmic into Peripheral Artery, Percutaneous Approach | |
3E053T | Destructive Agent | |
3E053TZ | Introduction of Destructive Agent into Peripheral Artery, Percutaneous Approach | |
3E053X | Vasopressor | |
3E053XZ | Introduction of Vasopressor into Peripheral Artery, Percutaneous Approach | |
3E053G | Other Therapeutic Substance | |
3E053GC | Introduction of Other Therapeutic Substance into Peripheral Artery, Percutaneous Approach | |
3E053GN | Introduction of Blood Brain Barrier Disruption Substance into Peripheral Artery, Percutaneous Approach | |
3E053V | Hormone | |
3E053VG | Introduction of Insulin into Peripheral Artery, Percutaneous Approach | |
3E053VH | Introduction of Human B-type Natriuretic Peptide into Peripheral Artery, Percutaneous Approach | |
3E053VJ | Introduction of Other Hormone into Peripheral Artery, Percutaneous Approach | |
3E053W | Immunotherapeutic | |
3E053WK | Introduction of Immunostimulator into Peripheral Artery, Percutaneous | |
3E053WL | Introduction of Immunosuppressive into Peripheral Artery, Percutaneous | |
|
ICD-10-CM-2023 Code Search Engine and PCS-2023 Code Search Engine |